Overview

Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis

Status:
Completed

Trial end date:
2018-10-01

Target enrollment:

Participant gender:

Summary

A randomized, double-blind, multicenter, active-controlled phase III study to evaluate the efficacy and safety of Levotuss CR tab. in comparison with Levotuss syrup in patients with cough due to acute or chronic bronchitis

Phase:

Phase 3

Details

Lead Sponsor:

Hyundai Pharm

Treatments:

Dipropizine